Consumer watchdog petitions FDA for black box warning on Amgen's Prolia

The FDA has warned patients using Amgen’s osteoporosis drug Prolia that stopping treatment could lead to an increased risk of spinal fractures. Now, a consumer watchdog said the warnings haven’t gone far enough.